| Literature DB >> 31020086 |
Martha Alehli Rangel-Hernández1,2, Alberto Aranda-Fraustro3, Gabriela Melendez-Ramirez4, Nilda Espínola-Zavaleta2.
Abstract
INTRODUCTION: Patients with chronic kidney disease undergoing haemodialysis (HD) therapy have high morbidity and mortality, the main causes are cardiovascular events followed by infectious disease. Infectious problems originate from the vascular access, especially when such access is through a central venous catheter. CASEEntities:
Keywords: Case report; Chronic kidney disease; Echocardiography; Haemodialysis; Infective endocarditis; Intracardiac mass
Year: 2018 PMID: 31020086 PMCID: PMC6426073 DOI: 10.1093/ehjcr/yty004
Source DB: PubMed Journal: Eur Heart J Case Rep ISSN: 2514-2119
Figure 3Magnetic resonance imaging in four chambers (A–D) and two chambers of the right cavities (E–H). The magnetic resonance imaging showed an oval mobile mass adhered to the floor of the right atrium, adjacent to the inferior vena cava, that measures 53 × 45 × 36 mm. In all the magnetic resonance imaging sequences the mass showed heterogeneous signal intensity. It was predominantly isointense in T1 (A, E) and T1 fat-sat (B, F) with hypointense centre. In T2-weighted (C, G), it was predominantly isointense, with some hyperintense zones and with hypointense centre. In T2* hypointense focus was also identified in the centre of the lesion. Fat content was not identified.
| 1987 | Diabetes mellitus Type 2 |
| 1989 | Systemic arterial hypertension |
| 2012 | Chronic renal disease secondary to diabetic nephropathy |
| 2013 | End-stage renal disease secondary to diabetic nephropathy |
| Renal substitution therapy in 2013 (starting with peritoneal dialysis modality) | |
| 2014 | Migrates from peritoneal dialysis to haemodialysis modality (with right jugular Mahurkar catheter) |
| 25 March 2016 | Intermittent high fever |
| 4 April 2016 | Purulent discharge at the Mahurkar jugular catheter insertion site |
| 7 April 2016 | Vancomycin intravenously was administered and out-patient management is recommended |
| 12 April 2016 | Patient was hospitalized and continued with antibiotic |
| Right jugular Mahurkar catheter was removed | |
| Left jugular Mahurkar catheter and right femoral access for dialysis were placed | |
| 14 April 2016 | Transthoracic echocardiography reported a mobile mass in the right atrium, suggestive of vegetation |
|
| |
| 2 May 2016 | The patient was referred to National Institute of Cardiology Ignacio Chavez in Mexico City |
| 6 May 2016 | Transthoracic echocardiogram |
| 11 May 2016 | Transoesophageal echocardiogram |
| Both reported a mobile mass in the right atrium | |
| 11 May 2016 | Cardiac magnetic resonance imaging: mobile oval mass attached to the floor of the right atrium suggestive of myxoma |
| 16 May 2016 | The case was discussed in a medical and surgical session, where patient was accepted for tumour surgical resection |
| 18 May 2016 | Surgical resection of the mass and treatment with antibiotic |
| 21 May 2016 | Subcutaneous administration of Enoxaparin 40 mg/24 h |
| 30 May 2016 | Histopathology reported an infected thrombus with Gram-positive bacterial colonies sensitive to cephalothin-prescribed for 2 weeks |
| 31 May 2016 | Repeat transthoracic echocardiogram without evidence of residual right atrial mass and without pericardial effusion |
| 3 June 2016 | Left brachiocephalic arteriovenous fistula |
| 4 June 2016 | Started with acenocoumarol orally |
| 7 June 2016 | Enoxaparin was suspended |
| 13 June 2016 | Last session of haemodialysis with ultrafiltration of 3000 mL |
| 14 June 2016 | Full recovery and discharge with indication of regularly follow-up in the clinic of nephrology in his city and cephalexin 500 mg every 8 h orally, for 4 weeks |
| 29 August 2017 | Last follow-up. Patient in good clinical condition |
Cardiac magnetic resonance imaging sequences for differential diagnosis of myxoma, thrombus, and infected thrombus
| MRI weighted sequences | Myxoma | Thrombus | Infected thrombus |
|---|---|---|---|
| T1 | Isointensity signal | Low to intermediate signal | Low to high signal |
| Acute thrombus-Intermediate signal | |||
| Chronic thrombus-Low signal | |||
| T2 | High signal | Low to intermediate signal | Low to high signal |
| Acute thrombus-intermediate signal | |||
| Chronic thrombus-low signal | |||
| T2* | Isointensity signal | Hypointensity signal (if acute) | Isointensity signal |
| T2-STIR | High signal intensity indicates a high water content caused by active inflammation and/or oedema | Low (if acute-high) | Low signal |
| T2 fat-Sat | High signal | Isointensity signal | Isointensity signal |
| Early perfusion | Lower vascularity | Avascularity | Avascularity |
| Early gadolinium | Minimal early contrast enhancement of the mass | No uptake | No uptake |
| Late gadolinium | No late enhancement (important discriminator from a thrombus) | No uptake | No uptake |
MRI: magnetic resonance imaging; STIR: short tau inversion recovery.